You are here

ENHANCE

Merck To Pay $688 Million To Shareholders For Delaying Vytorin Results

Forbes

Thu, 02/14/13 - 09:57 am

Merck Settles Shareholder Suit Over Enhance Trial

Pharmalot

Wed, 10/19/11 - 10:38 am

Schering Plough

Lawsuit: Schering execs sat on Vytorin results

Fierce Pharma

Tue, 10/13/09 - 06:28 pm

Schering Plough